Schott Pharma announced that it opened up new production lines for both standard and sterile ready-to-use (RTU) glass vials. The company invested more than $60 million, largely funded by the Biomedical Advanced Research and Development Authority (BARDA), to strengthen the resilience of the U.S. pharmaceutical supply chain. It hopes to ensure reliable domestic production of…

Nearly every production stage in biopharmaceutical manufacturing depends on highly purified water systems that must consistently meet strict regulatory standards. Why are water quality standards important in biopharmaceutical manufacturing? Biopharmaceutical facilities generally rely on two primary types of purified water. Purified water (PW) is commonly used in nonsterile pharmaceutical manufacturing and equipment cleaning processes. Water…

Niowave announced today that it broke ground on a new $75 million production facility in Lansing, Michigan. The isotope manufacturing plant significantly expands the company’s manufacturing footprint and strengthens the domestic supply of Actinium‑225 (Ac‑225), a critical isotope used in next‑generation targeted cancer therapies. The isotope supports targeted cancer therapies designed to destroy cancer cells…

Fujifilm Cellular Dynamics announced that it opened a new headquarters and manufacturing facility in Madison, Wisconsin. The company expects its new site to quadruple its capacity for human-induced pluripotent stem cell (iPSC)-based research products and services manufacturing footprint. It also expects to expand capabilities across its research product portfolio. The new expansion comes as part…

As tighter European F-Gas rules and the rollout of lower-GWP refrigerants force changes in industrial chillers and process cooling, German thermal-management specialist Pfannenberg has introduced an engineering-led safety system. The new offering is intended to help facilities, including pharmaceutical processing sites, manage the refrigerant transition without compromising equipment safety or audit trails. The system, Pfannenberg…

Eli Lilly (NYSE:LLY) announced today that it has committed an additional $4.5 billion investment across certain Indiana manufacturing sites. The company’s commitment extends to two of its three locations in Lebanon, Indiana. It brings its total Indiana capital expansion commitments since 2020 to more than $21 billion. This marks the latest investment across the U.S.,…

Thermo Fisher Scientific today announced the introduction of the Gibco CTS DynaXS single-use bioreactor for cell therapy manufacturing. Waltham, Massachusetts–based Thermo Fisher designed the expansion platform to help cell therapy developers scale manufacturing with control, flexibility and regulatory readiness. Thermo Fisher said its stirred-tank, single-use system supports cell expansion across development and early clinical volumes.…

AstraZeneca has officially opened its new active pharmaceutical ingredient (API) manufacturing facility in Dublin, Ireland. IDA Ireland, the foreign direct investment arm of the Irish government, said in a news release that the new facility brings advanced automation, AI and innovative new technologies into one place to continue to innovate in science and manufacturing. “Healthcare…

Novartis announced today that it plans to add a new active pharmaceutical ingredient (API) manufacturing plant in North Carolina. The company expects the facility in Morrisville to focus on APIs for solid dosage tablets, capsules and RNA therapeutics. Novartis said its new facility marks a critical step to strengthen end-to-end U.S. production capability. It comes…

West Pharmaceutical Services (NYSE:WST) announced today that it launched its NovaPure 0.5 mL plunger for ISO glass syringes. Exton, Pennsylvania-based West designed the syringes to meet the performance and quality requirements for ophthalmic drug applications. The plunger is West’s newest ready-to-use elastomer component within the NovaPure portfolio. This includes the existing 1 mL and 1-3…